Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- The Healthcare MBA: One Fast Track in a Slow Economy
- The bottom line: Healthcare is hiring and B-schools can't churn out enough MBAs to fill jobs in the $2.26 trillion industry. Top...
- Articles 2009-02-09
Additional Resources
- IMS HEALTH Unveils Internet Portal; New Internet-based Information Environment for Pharmaceutical Companies to Access All IMS HEALTH Products and Services
- LONDON--HealthWire--March 22, 1999--IMS HEALTH (NYSE:RX) today demonstrated its prototype Internet portal at a meeting with analysts in New York City. The portal, called "I2" (I-squared) is designed for IMS HEALTH's global pharmaceutical company customers and will enable real-time access to all IMS HEALTH information products and services, while providing a...
- Research articles 1999-03-22
- IMS HEALTH.(IMS Health introduces a new database service that tracks the pharma-chemical market)(Business Brief)(Brief Article)
- IMS HEALTH has launched Tracer, its new CD-ROM database service that tracks producers of leading drugs. The service presents a comprehensive overview of the pharma-chemical manufacturer marketplace. IMS has also received a commercial ... IMS HEALTH has launched Tracer,...
- Research articles 1998-11-02
- IMS HEALTH And TriZetto Terminate Merger Agreement; New Strategic Alliance Includes TriZetto's Acquisition Of Erisco; Plus HealthWeb and Data Agreement with IMS HEALTH
- Business/Health & Science Editors WESTPORT, CT and NEWPORT BEACH, CA--BW HealthWire--May 16, 2000 IMS HEALTH (NYSE:RX) and The TriZettoR Group, Inc. (Nasdaq:TZIX) today jointly announced a strategic alliance under which TriZetto will acquire Erisco Managed Care Technologies, a subsidiary of IMS HEALTH, for TriZetto stock. Further, IMS HEALTH...
- Research articles 2000-05-16
- Bayer plc Selects IMS HEALTH Strategic Technologies to Implement Next-Generation Sales and Marketing System
- LONDON--BW HealthWire--Feb. 10, 1999--IMS HEALTH (NYSE:RX) today announced that Bayer plc has chosen its IMS HEALTH Strategic Technologies unit to support 300 users throughout Bayer plc in the UK and Ireland with a next-generation sales support system. Bayer will migrate to a state-of-the-art Windows-based sales and marketing support technology with...
- Research articles 1999-02-11
- Kill Bw1289, Ct-Ims-Health/Yetter
- Please KILL BW1289, (CT-IMS-HEALTH/YETTER)RX IMS HEALTH Appoints Wayne P. Yetter Chief Operating Officer, which ran on Business Wire at 9:30 ET on 10/21/1999 REPLACE with BW1304 (CT-IMS-HEALTH/YETTER) IMS HEALTH Appoints Wayne P. Yetter Chief Operating Officer, which ran on Business Wire at 9:39 ET on 10/21/1999.
- Research articles 1999-10-21
- IMS HEALTH.(forms joint venture with Hergiswil)
- IMS HEALTH, a London-based information service, has formed a 50-50 joint venture with Hergiswil, Switzerland-based Institut fuer Marktanalysen AG. The new company, IHA.IMS ... IMS HEALTH, a London-based information service, has formed a 50-50 joint venture with Hergiswil, Switzerland-based Institut fuer Marktanalysen AG. The new...
- Research articles 1998-09-07
- Is IMS Health a Good Investment?
- Matt Darrah submits: Below is our investment analysis for IMS Health RX. Executive Summary Attractive and sustainable return on invested capital Exceeded 100% over the past ten years High customer switching costs should help sustain returns on...
- External links 2009-08-20
- IMS Health Is Being Stolen from Shareholders
- Vitaliy N. Katsenelson, CFA submits: It was announced Thursday that IMS Health RX was to be stolen from its shareholders for $4 billion or about $22 share; a private equity firm will buy them out. IMS Health should have free cash flows this year of over $340 million (the...
- External links 2009-11-05
- IMS to acquire PharMetrics.(Off the BOARD: Covering the county's public companies)(IMS Health Inc)(Brief Article)
- IMS Health has announced a definitive agreement to acquire PharMetrics Inc., a leading U.S. provider of business intelligence. The combination will provide health-care stakeholders pharmaceutical, medical and hospital insights to better manage the de IMS Health has announced a definitive agreement to acquire PharMetrics Inc.,...
- Research articles 2005-06-13
- IMS Health names new CEO.(Off the board: covering the county's public companies)(Brief Article)
- The IMS Health board of directors has named David R. Carlucci as chief executive officer of the company and elected him to the board effective Jan. 1. Carlucci currently is president and chief operating officer of IMS. Carlucci succeeds David M. T The...
- Research articles 2004-11-15
- IMS Health, Inc. Q2 2006 Earnings Conference Call Transcript (RX)
- Earnings Call Excerpt IMS Health RX Q2 2006 Earnings Conference Call July 19, 2006, 5:00 pm ET Executives Darcie Peck,Vice President of Investor Relations Dave Carlucci, Chairman and Chief Executive Officer Nancy Cooper, Chief Financial Officer Gilles Pagot, Executive Vice...
- Earnings calls 2006-07-19
- IMS HEALTH Announces Multi-Year Agreement With Wyeth-Ayerst Laboratories; New Contract Expands Strategic Relationship
- LONDON--BW HealthWire--March 4, 1999--Expanding its strategic role with one of the world's leading pharmaceutical companies, IMS HEALTH (NYSE:RX) has announced a multi-year agreement with Wyeth-Ayerst Laboratories to provide access to IMS HEALTH's pharmaceutical sales, prescription and market research information. The agreement supports Wyeth-Ayerst's sales management and market research business applications....
- Research articles 1999-03-04
- Victoria R. Fash Named Ceo Of Ims Health; Robert E. Weissman Continues As Chairman Of The Board
- WESTPORT, CT--BW HealthWire--March 19, 1999--IMS HEALTH (NYSE:RX) today announced that Victoria R. Fash, president and chief operating officer, has assumed responsibilities as chief executive officer of the corporation following today's 1999 Annual Shareholders Meeting. Fash, 48, succeeds Robert E. Weissman, 58, who continues in his role as chairman of the...
- Research articles 1999-03-19
- IMS HEALTH Strategic Technologies to Enhance Wyeth Australia Sales Force Effectiveness
- LONDON--BW HealthWire--Feb. 15, 1999--IMS HEALTH (NYSE:RX) today announced that Wyeth Australia, a unit of American Home Products, has awarded IMS HEALTH Strategic Technologies a three-year contract for delivery of strategic sales and marketing management information technology to Wyeth Australia's four sales divisions. PremiereSM Notes technology will replace paper-based systems currently...
- Research articles 1999-02-15
- IMS Health.(Looking Inside)(announced an agreement to provide global drug information to the World Health Organization Collaborating Center for International Drug Monitoring for its drug dictionary)(Brief Article)
- IMS Health (NYSE: RX) of Fairfield announced an agreement to provide global drug information to the World Health Organization Collaborating Center for International Drug Monitoring for its drug dictionary; used by government health authorities and ph IMS Health (NYSE: RX) of Fairfield announced an agreement to...
- Research articles 2003-11-17
- IMS reports revenue growth.(Off the board: covering the county's public companies)(IMS Health Inc.)(Brief Article)
- Fairfield-based IMS Health reported fourth-quarter 2004 revenues of $443.7 million, up 16 percent compared with revenues for the fourth quarter of 2003. Fourth-quarter diluted earnings per share were 32 cents, up 14 percent, compared with 28 cents in Fairfield-based IMS Health reported fourth-quarter 2004 revenues of...
- Research articles 2005-02-28
- IMS Health Q4 2005 Earnings Conference Call Transcript (RX)
- Earnings Call Excerpt IMS Health RX Q4 2005 Earnings Conference Call January 31st 2006, 8:30 AM. Executives: Darcie Peck, Vice President, Investor Relations David Carlucci, President and CEO Nancy Cooper, CFO and Sr. VP Analysts: Larry Marsh, Lehman Brothers ...
- Earnings calls 2006-02-03
- Pharma resilient during economic slog, says IMS Health
- The global market for pharmaceuticals is expected to grow by 4%-6% in 2010 – exceeding $825 billion – due in part to near-term growth in the US, according to an IMS Health forecast.The forecast also predicts a 4%-7% growth over the next five years – a one percentage point increase...
- News items 2009-10-09
- IMS Health Launches Powerful Global Portfolio of Promotion Management Solutions for the Pharmaceutical Industry; IMS Promo.360 Helps Clients Maximize Promotional ROI and Improve Brand Performance Across Markets
- FAIRFIELD, Conn. -- IMS Health (NYSE: RX) today announced the launch of IMS Promo.360TM, a powerful portfolio of global offerings that equips pharmaceutical marketing teams with a comprehensive, consistent and tailored approach to promotion management. The offerings combine the strength of IMS's global information assets and business expertise to drive...
- Research articles 2005-11-15
- << Previous
- page 1 of 1
- Next >>
Presented by American Express